JNJ Johnson & Johnson

Price (delayed)

$165.02

Market cap

$434.56B

P/E Ratio

28.75

Dividend/share

$4.09

EPS

$5.74

Enterprise value

$455.51B

Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceutical, and consumer packaged goods. Its common stock is a component of the Dow Jones ...

Highlights
The quick ratio has increased by 7% QoQ
JNJ's equity is up by 7% year-on-year and by 4% since the previous quarter
JNJ's price to earnings (P/E) is 59% lower than its 5-year quarterly average of 70.0 but 12% higher than its last 4 quarters average of 25.7
Johnson & Johnson's debt has increased by 22% YoY but it has decreased by 4.7% from the previous quarter

Key stats

What are the main financial stats of JNJ
Market
Shares outstanding
2.63B
Market cap
$434.56B
Enterprise value
$455.51B
Valuations
Price to earnings (P/E)
28.75
Price to book (P/B)
6.59
Price to sales (P/S)
5.16
EV/EBIT
25.8
EV/EBITDA
18.2
EV/Sales
5.41
Earnings
Revenue
$84.21B
EBIT
$17.66B
EBITDA
$25.03B
Free cash flow
$20.85B
Per share
EPS
$5.74
Free cash flow per share
$7.92
Book value per share
$25.04
Revenue per share
$32
TBVPS
$32.59
Balance sheet
Total assets
$172.56B
Total liabilities
$106.72B
Debt
$33.61B
Equity
$65.83B
Working capital
$11.6B
Liquidity
Debt to equity
0.51
Current ratio
1.28
Quick ratio
0.97
Net debt/EBITDA
0.84
Margins
EBITDA margin
29.7%
Gross margin
66.2%
Net margin
17.9%
Operating margin
24.1%
Efficiency
Return on assets
8.9%
Return on equity
23.6%
Return on invested capital
27.3%
Return on capital employed
13.4%
Return on sales
21%
Dividend
Dividend yield
2.48%
DPS
$4.09
Payout ratio
71.3%

JNJ stock price

How has the Johnson & Johnson stock price performed over time
Intraday
0.32%
1 week
-0.34%
1 month
-3.05%
1 year
14.23%
YTD
4.85%
QTD
0.41%

Financial performance

How have Johnson & Johnson's revenue and profit performed over time
Revenue
$84.21B
Gross profit
$55.79B
Operating income
$20.29B
Net income
$15.12B
Gross margin
66.2%
Net margin
17.9%
Johnson & Johnson's net margin has decreased by 14% YoY
Johnson & Johnson's net income has decreased by 12% YoY but it has increased by 2.7% QoQ
Johnson & Johnson's operating margin has decreased by 6% YoY but it has increased by 2.1% from the previous quarter
The operating income has declined by 4.3% year-on-year but it rose by 4.1% since the previous quarter

Growth

What is Johnson & Johnson's growth rate over time

Valuation

What is Johnson & Johnson stock price valuation
P/E
28.75
P/B
6.59
P/S
5.16
EV/EBIT
25.8
EV/EBITDA
18.2
EV/Sales
5.41
JNJ's price to earnings (P/E) is 59% lower than its 5-year quarterly average of 70.0 but 12% higher than its last 4 quarters average of 25.7
The EPS has contracted by 12% YoY but it has grown by 2.7% from the previous quarter
JNJ's price to book (P/B) is 17% more than its 5-year quarterly average of 5.6 and 6% more than its last 4 quarters average of 6.2
JNJ's equity is up by 7% year-on-year and by 4% since the previous quarter
The price to sales (P/S) is 12% more than the 5-year quarterly average of 4.6 and 7% more than the last 4 quarters average of 4.8

Efficiency

How efficient is Johnson & Johnson business performance
Johnson & Johnson's return on invested capital has decreased by 27% YoY
The return on assets has declined by 19% year-on-year
The company's return on equity fell by 17% YoY
The ROS has contracted by 12% YoY but it has grown by 4% from the previous quarter

Dividends

What is JNJ's dividend history
DPS
$4.09
Dividend yield
2.48%
Payout ratio
71.3%
Recent dividends

Financial health

How did Johnson & Johnson financials performed over time
JNJ's total assets is 62% greater than its total liabilities
Johnson & Johnson's total liabilities has increased by 14% YoY but it has decreased by 4.4% from the previous quarter
JNJ's total assets is up by 11% year-on-year
Johnson & Johnson's debt is 49% less than its equity
Johnson & Johnson's debt has increased by 22% YoY but it has decreased by 4.7% from the previous quarter
The company's debt to equity rose by 13% YoY but it fell by 9% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.